Completed PHASE1 INTERVENTIONAL 4-arm NCT03306667

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

Clinical Pharmacology Study of FYU-981 for Subjects With Hepatic Insufficiency

Sponsor: Fuji Yakuhin Co., Ltd.

Conditions Healthy Hepatic Insufficiency

Interventions FYU-981

Updated 7 times since 2017 Last updated: Sep 21, 2018 Started: Oct 6, 2017 Primary completion: Jun 20, 2018 Completion: Jun 25, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy and Hepatic Insufficiency, this trial is completed. The trial is conducted by Fuji Yakuhin Co., Ltd. and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Oct 2018 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE1

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Oct 2017 — Dec 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Data source: Mochida Pharmaceutical Company, Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokyo, Japan